Longevity Startups

Sano Chemicals is a clinical-stage drug development company creating new chemical entities (NCEs) as first-in-class treatments for antimicrobial-resistant fungi and bacteria, with additional research into cancer applications. It develops novel drug products aimed at infectious diseases where existing treatments have become ineffective.

0 investors

Sen-Jam is a computational drug discovery and development company developing a class of anti-inflammatory therapeutics based on combinations of already-approved small molecules (NSAIDs and antihistamines). Its pipeline targets conditions including alcohol hangover, viral and coronavirus infections, vaccine side effects, arthritis, and opioid dependence, tolerance, and withdrawal.

0 investors

Seniorly operates an online directory of senior living communities and connects families with local advisors and virtual tools to find assisted living, memory care, and independent living options. It provides free advisory services, cost calculators, care quizzes, and guides for families in the United States.

0 investors

Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.

0 investors

Sperity Health provides early detection and preventive health screening programs for individuals and employers, coordinating advanced diagnostics, wearable monitoring, and personalized care across sleep, nutrition, exercise, and preventive screening to shift healthcare from reactive to proactive.

0 investors

Tinos Tx develops first-in-class small molecule inhibitors targeting the RNA demethylase FTO to destabilize tumor-driving RNA and kill cancer cells. The company builds on research into how RNA methylation controls cellular survival to create cancer therapeutics.

0 investors

TNF Pharmaceuticals is a clinical-stage biopharma company developing therapies for autoimmune and inflammatory diseases, with lead candidates including MYMD-1, an oral TNF-alpha inhibitor, and Supera-CBD, a synthetic cannabidiol analog.

0 investors

Upgrade Labs offers in-person recovery and performance facilities where clients receive non-invasive cell health scans, biomarker testing, and personalized protocols guided by "biohacker" technicians. It serves individuals seeking to improve physical recovery, fitness, and overall wellness through technology-based assessments and optimization plans.

0 investors

Vitro Biopharma is a biotechnology company developing Wharton's jelly-derived (umbilical cord) mesenchymal stem cell therapies for autoimmune diseases and inflammatory disorders. It manufactures its cell therapy product candidates under cGMP conditions with ISO 9001:2015 and ISO 13485:2016 certification for the immunology and inflammation market.

0 investors